(株)ファンペップの貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4881/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2022/04/28 | 日証協 | 265,900株 | -5.94% | 26,800株 | +66.46% | 756,907株 | -1.16% | 26,200株 | +79.45% |
| 2022/04/22 | 日証協 | 282,700株 | +1.47% | 16,100株 | -64.38% | 765,807株 | +0.46% | 14,600株 | -38.91% |
| 2022/04/15 | 日証協 | 278,600株 | -3.96% | 45,200株 | +5.36% | 762,307株 | -0.21% | 23,900株 | -19.8% |
| 2022/04/08 | 日証協 | 290,100株 | -8.46% | 42,900株 | +47.42% | 763,907株 | -2.5% | 29,800株 | -51.49% |
| 2022/04/01 | 日証協 | 316,900株 | -8.62% | 29,100株 | -11.01% | 783,507株 | +2.77% | 61,430株 | -18.32% |
| 2022/03/25 | 日証協 | 346,800株 | -7.35% | 32,700株 | +3.81% | 762,389株 | -0.42% | 75,212株 | +202.06% |
| 2022/03/18 | 日証協 | 374,300株 | -10.07% | 31,500株 | -36.62% | 765,577株 | -2.99% | 24,900株 | -30.83% |
| 2022/03/11 | 日証協 | 416,200株 | +3.53% | 49,700株 | +72.57% | 789,177株 | -1.24% | 36,000株 | +93.55% |
| 2022/03/04 | 日証協 | 402,000株 | -9.48% | 28,800株 | -49.3% | 799,077株 | -2.7% | 18,600株 | -7.47% |
| 2022/02/25 | 日証協 | 444,100株 | +3.64% | 56,800株 | +119.31% | 821,277株 | +1.07% | 20,102株 | +26.41% |
| 2022/02/18 | 日証協 | 428,500株 | -4.12% | 25,900株 | -19.06% | 812,575株 | -0.71% | 15,902株 | -35.62% |
| 2022/02/10 | 日証協 | 446,900株 | +4.66% | 32,000株 | +3.56% | 818,373株 | +1.84% | 24,700株 | +21.08% |
| 2022/02/04 | 日証協 | 427,000株 | -7.4% | 30,900株 | -71.28% | 803,573株 | -2.69% | 20,400株 | -53% |
| 2022/01/28 | 日証協 | 461,100株 | +2.9% | 107,600株 | +1.41% | 825,773株 | +0.36% | 43,400株 | +2.6% |
| 2022/01/21 | 日証協 | 448,100株 | +14.87% | 106,100株 | +8.93% | 822,773株 | +4.23% | 42,300株 | +14.87% |
| 2022/01/14 | 日証協 | 390,100株 | +0.54% | 97,400株 | -5.89% | 789,351株 | +1.21% | 36,823株 | -52.24% |
| 2022/01/07 | 日証協 | 388,000株 | -7.09% | 103,500株 | +162.69% | 779,950株 | +3.7% | 77,100株 | +145.78% |
| 2021/12/30 | 日証協 | 417,600株 | 0% | 39,400株 | 0% | 752,129株 | 0% | 31,370株 | 0% |
| 2021/12/24 | 日証協 | 417,600株 | -15.21% | 39,400株 | +885% | 752,129株 | -6.87% | 31,370株 | -42.75% |
※株式分割は考慮していませんのでご注意ください。
Page Top